We are live on ! Find out more

448 hedge funds and large institutions have $9.38B invested in Sanofi in 2016 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 159 increasing their positions, 161 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more call options, than puts

Call options by funds: $18.5M | Put options by funds: $16M

0.29% more ownership

Funds ownership: 17.57%17.86% (+0.29%)

1% less repeat investments, than reductions

Existing positions increased: 159 | Existing positions reduced: 161

4% less capital invested

Capital invested by funds: $9.76B → $9.38B (-$375M)

6% less funds holding

Funds holding: 476448 (-28)

36% less funds holding in top 10

Funds holding in top 10: 117 (-4)

37% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 63

Holders
448
Holders Change
-28
Holders Change %
-5.88%
% of All Funds
11.94%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.19%
New
40
Increased
159
Reduced
161
Closed
63
Calls
$18.5M
Puts
$16M
Net Calls
+$2.45M
Net Calls Change
-$9.29M

SNY Hedge Fund Activity: Q1 2016 in Review

448 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2016, worth a combined $9.38B — down 3.8% from $9.76B a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of SNY and 40 opened new positions — a net loss of 23 holders — while 161 trimmed existing stakes and 159 added.

The largest buyer was Dodge & Cox, adding an estimated $145M. The largest seller was Sound Shore Management, exiting entirely with an estimated $152M sold.

  • 448 institutional investors held Sanofi (SNY) as of Q1 2016, down from 476 in Q4 2015.
  • Funds reported $9.38B of Sanofi stock for Q1 2016, down 3.8% quarter-over-quarter.
  • 40 funds opened new Sanofi positions in Q1 2016 and 63 closed out, a net change of -23 holders.
  • The largest Sanofi buyer in Q1 2016 was Dodge & Cox, an estimated $145M added.
  • The largest Sanofi seller in Q1 2016 was Sound Shore Management, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2016.